Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (ISRCTN18053239) titled 'A high-protection sunscreen with natural ingredients helps reduce dark patches and signs of skin aging on the face' on Oct. 27.
Study Type: Interventional
Study Design:
Pilot prospective open-label study with a total duration of three months followed by a three-month follow-up (Efficacy, Treatment)
Primary Sponsor: Cantabria Labs Difacooper
Condition:
The use of a sunscreen 50+ containing polypodium leucotomos extract, ellagic acid and niacinamide in patients with melasma
Skin and Connective Tissue Diseases
Intervention:
Patients were instructed to apply the product every morning and reapply it every two hou...